SE0403172D0 - Manufacturing process - Google Patents

Manufacturing process

Info

Publication number
SE0403172D0
SE0403172D0 SE0403172A SE0403172A SE0403172D0 SE 0403172 D0 SE0403172 D0 SE 0403172D0 SE 0403172 A SE0403172 A SE 0403172A SE 0403172 A SE0403172 A SE 0403172A SE 0403172 D0 SE0403172 D0 SE 0403172D0
Authority
SE
Sweden
Prior art keywords
manufacturing process
manufacturing
tetrahydropyridazino
dione
quinoline
Prior art date
Application number
SE0403172A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0403172A priority Critical patent/SE0403172D0/sv
Publication of SE0403172D0 publication Critical patent/SE0403172D0/sv
Priority to PCT/SE2005/002019 priority patent/WO2006068617A1/en

Links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0403172A 2004-12-23 2004-12-23 Manufacturing process SE0403172D0 (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0403172A SE0403172D0 (sv) 2004-12-23 2004-12-23 Manufacturing process
PCT/SE2005/002019 WO2006068617A1 (en) 2004-12-23 2005-12-22 A new manufacturing process for the preparation of halogen substituted 4-hydroxy-2-(2-chloro-4-methylphenyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0403172A SE0403172D0 (sv) 2004-12-23 2004-12-23 Manufacturing process

Publications (1)

Publication Number Publication Date
SE0403172D0 true SE0403172D0 (sv) 2004-12-23

Family

ID=34102120

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0403172A SE0403172D0 (sv) 2004-12-23 2004-12-23 Manufacturing process

Country Status (2)

Country Link
SE (1) SE0403172D0 (sv)
WO (1) WO2006068617A1 (sv)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020062983A (ko) * 1999-12-23 2002-07-31 아스트라제네카 아베 통증의 치료 방법 및 조성물
NZ519390A (en) * 1999-12-23 2003-07-25 Astrazeneca Ab 7-Chloro-4-hydroxy-2-(2-chloro-4-methylphenyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione useful for treating pain
WO2001047524A1 (en) * 1999-12-23 2001-07-05 Astrazeneca Ab Method and composition for the treatment of pain
JP2003519145A (ja) * 1999-12-23 2003-06-17 アストラゼネカ・アクチエボラーグ 痛みの処置のための化合物および方法
DE60026883T2 (de) * 1999-12-23 2006-11-23 Astrazeneca Ab Methoden und zusammensetzungen zur behandlung von schmerzen
JP2003519148A (ja) * 1999-12-23 2003-06-17 アストラゼネカ・アクチエボラーグ 痛みの処置のための化合物および方法

Also Published As

Publication number Publication date
WO2006068617A1 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
BRPI0519302A2 (pt) etanossulfonato de sais de 1-(2-metilpropil)-1h-imidazo[4,5-c][1,5]naftiridin-4-amin o e metanossulfonato de 1-(2-metilpropil)-1h-imidazo[4,5-c][1,5]naftiridin-4-amin a, composiÇÕes contendo os mesmos, processos de preparaÇço e uso
ECSP055809A (es) Inhibidores 4-oxo-1-(3-fenil sustituido)-1,4-dihidro-1,8-naftiridina-3-carboxamida de la fosfodiesterasa-4
WO2006086633A3 (en) Substituted fused [1,2]imidazo[4,5-c] ring compounds and methods
WO2001066534A3 (en) Cyclic and bicyclic diamino histamine-3 receptor antagonists
WO2007106852A3 (en) Substituted fused[1,2]imidazo[4,5-c] ring compounds and methods
JP2009524676A5 (sv)
PE20141557A1 (es) Derivado de pirazoloquinolina
PA8678901A1 (es) Derivados de quinolina como agentes antibacteriales
PE20070002A1 (es) Compuestos derivados de heteroaril como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa tipo i
ECSP10010197A (es) Derivados de piridina y pirazina útiles en el tratamiento de trastornos de proliferación celular
BR0309463A (pt) Derivados de 1,2,3,4,7,8-hexaidro-6h-[1,4]diazepino[6,7,1-ij]quinolina como agentes antipsicóticos e antiobesidade
WO2006074003A3 (en) CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS
ECSP055807A (es) Quinolinilpirrolopirazoles
UY30183A1 (es) Derivados de quinolina
MX2007005478A (es) Formulaciones de derivados de [1,4]diazepino[6,7,1-ij]quinolina.
MY137609A (en) Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation
WO2006066950A3 (de) Tricyclische aminoalkohole, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
WO2007083188A3 (en) Improved process for the preparation of an optically active 5h-pyrrolo [3,4-b] pyrazine derivative
ATE486602T1 (de) Pyrrolo (3, 2, 1-ij) chinolin-4-on-derivate zur behandlung von tuberkulose
ATE466842T1 (de) 3-substituierte pyridinderivate als h3- antagonisten
CY1111227T1 (el) Mεθοδος παρασκευης 1-υποκατασταθεισων ενωσεων 1η-ιμιδαζο[4,5-c]κινολιν-4-αμινης και ενδιαμεσα γι' αυτην.
DE602005007765D1 (de) Neue indol- oder benzimidazol-derivate
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
MA28179A1 (fr) Nouveau compose, compositions correspondantes, methodes de fabrication et/ou de traitement
WO2007050353A3 (en) Tricyclic compounds useful as oxytocin receptor agonists